Journal
BIOMARKERS IN MEDICINE
Volume 8, Issue 1, Pages 51-57Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/bmm.13.134
Keywords
algorithm; biomarkers; prodrome; psychosis; schizophrenia; treatment
Categories
Funding
- NIMH NIH HHS [R01 MH060720, K24 MH076191] Funding Source: Medline
Ask authors/readers for more resources
Numerous biomarkers for somatic disorders are used in routine medical practice. Yet, despite remarkable advances in mental health research, we are not able to identify biomarkers with established clinical utility for mental disorders such as schizophrenia. While identification and characterization of biomarkers are crucial first steps in this process, their predictive diagnostic and treatment utility need to be better developed for clinical practice. The heterogeneity of psychotic disorders etiologically, pathologically and symptomatically presents both a challenge and an opportunity for the use of biomarkers in clinical practice. Simply said, a single biomarker might not exist that necessitates the search for a biomarker profile. In this review we discuss research findings in light of such an approach. We summarize some examples of emerging biomarkers in early psychosis research and delineate how these can be applied to a clinical setting to inform treatment on an individual basis fostering a personalized treatment approach.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available